Publication:
2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0.

cris.virtual.author-orcid0000-0001-9346-5146
cris.virtual.author-orcid0000-0001-5297-6062
cris.virtualsource.author-orcid1094e4f3-45b0-4775-88b6-673285317697
cris.virtualsource.author-orcid91a3060c-0e74-4217-944d-3471766e2083
datacite.rightsopen.access
dc.contributor.authorRyom, L
dc.contributor.authorCotter, A
dc.contributor.authorDe Miguel, R
dc.contributor.authorBéguelin, Charles Antoine
dc.contributor.authorPodlekareva, D
dc.contributor.authorArribas, J R
dc.contributor.authorMarzolini, C
dc.contributor.authorMallon, Pgm
dc.contributor.authorRauch, Andri
dc.contributor.authorKirk, O
dc.contributor.authorMolina, J M
dc.contributor.authorGuaraldi, G
dc.contributor.authorWinston, A
dc.contributor.authorBhagani, S
dc.contributor.authorCinque, P
dc.contributor.authorKowalska, J D
dc.contributor.authorCollins, S
dc.contributor.authorBattegay, M
dc.date.accessioned2024-09-02T16:12:25Z
dc.date.available2024-09-02T16:12:25Z
dc.date.issued2020-11
dc.description.abstractBACKGROUND The European AIDS Clinical Society (EACS) Guidelines cover key aspects of HIV management with major updates every two years. GUIDELINE HIGHLIGHTS The 2019 Guidelines were extended with a new section focusing on drug-drug interactions and other prescribing issues in people living with HIV (PLWH). The recommendations for treatment-naïve PLWH were updated with four preferred regimens favouring unboosted integrase inhibitors. A two-drug regimen with dolutegravir and lamivudine, and a three-drug regimen including doravirine were also added to the recommended initial regimens. Lower thresholds for hypertension were expanded to all PLWH and for cardiovascular disease prevention, the 10-year predicted risk threshold for consideration of antiretroviral therapy (ART) modification was lowered from 20% to 10%. Frailty and obesity were added as new topics. It was specified to use urine albumin to creatinine ratio to screen for glomerular disease and urine protein to creatinine ratio for tubular diseases, and thresholds were streamlined with the Kidney Disease: Improving Global Outcomes (KDIGO) recommendations. Hepatitis C virus (HCV) treatment recommendations were split into preferred and alternative treatment options. The algorithm for management of recently acquired HCV infection was updated and includes recommendations for early chronic infection management. Treatment of resistant tuberculosis (TB) was streamlined with the World Health Organization (WHO) recommendations, and new tables on immune reconstitution inflammatory syndrome, on when to start ART in the presence of opportunistic infections and on TB drug dosing were included. CONCLUSIONS The EACS Guidelines underwent major revisions of all sections in 2019. They are available in four different formats including a new interactive web-based version and are translated into Chinese, French, German, Japanese, Portuguese, Russian and Spanish.
dc.description.numberOfPages8
dc.description.sponsorshipUniversitätsklinik für Infektiologie
dc.identifier.doi10.7892/boris.146424
dc.identifier.pmid32885559
dc.identifier.publisherDOI10.1111/hiv.12878
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/37081
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofHIV medicine
dc.relation.issn1464-2662
dc.relation.organizationDCD5A442BB13E17DE0405C82790C4DE2
dc.subjectEuropean AIDS Clinical Society (EACS) Guidelines HIV antiretroviral treatment comorbidities drug-drug interactions hepatitis B virus hepatitis C virus opportunistic infections prescribing in elderly patients
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.title2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0.
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage624
oaire.citation.issue10
oaire.citation.startPage617
oaire.citation.volume21
oairecerif.author.affiliationUniversitätsklinik für Infektiologie
oairecerif.author.affiliationUniversitätsklinik für Infektiologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2020-09-10 06:04:52
unibe.description.ispublishedpub
unibe.eprints.legacyId146424
unibe.refereedtrue
unibe.subtype.articlereview

Files

Original bundle
Now showing 1 - 1 of 1
Name:
hiv.12878 (1).pdf
Size:
219.59 KB
Format:
Adobe Portable Document Format
License:
https://creativecommons.org/licenses/by-nc-nd/4.0
Content:
published

Collections